Edoxaban Tosylate
6 NDCs across 1 manufacturer|0 Generic,6 Brand
Edoxaban Tosylate is used to treat pulmonary embolism and venous thrombosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 8, 2015. In 2024, Medicare Part D spent $5 million on Edoxaban Tosylate across 7,868 claims for 1,536 beneficiaries.
Edoxaban Tosylate is available as 6 NDCs from 1 manufacturer (0 generic, 6 brand), with NADAC prices from $12.46 to $15.51 per EA — a 24% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
6
0G / 6B
Manufacturers
1
competing in market
Price Spread
$12.46 – $15.51
per EA
7d Activity
avg +0.0% WoW · of 6 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Daiichi Sankyo Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Factor Xa Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing EDOXABAN TOSYLATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SAVAYSA 60 MG TABLET | $15.5115 per EA | — |
SAVAYSA 30 MG TABLET | $15.4815 per EA | — |
SAVAYSA 30 MG TABLET | $12.4819 per EA | — |
SAVAYSA 30 MG TABLET | $12.4819 per EA | — |
SAVAYSA 60 MG TABLET | $12.4609 per EA | — |
SAVAYSA 60 MG TABLET | $12.4609 per EA | — |
Frequently Asked Questions
What is Edoxaban Tosylate used to treat?
Edoxaban Tosylate is used to treat pulmonary embolism and venous thrombosis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Edoxaban Tosylate?
In 2024, Medicare Part D spent $5 million on Edoxaban Tosylate across 7,868 claims for 1,536 beneficiaries.
How many Edoxaban Tosylate products are on the market?
The Edoxaban Tosylate drug market contains 6 NDCs from 1 manufacturer — 0 generic and 6 brand products.
What is the price range for Edoxaban Tosylate?
NADAC reference prices for Edoxaban Tosylate range from $12.4609 to $15.5115 per EA — a 24% difference between cheapest and most expensive.
Which manufacturers make Edoxaban Tosylate?
1 manufacturer lists Edoxaban Tosylate in NADAC. Ranked by number of NDCs, the largest are Daiichi Sankyo Inc. (6).